Regulation of Aromatase Expression in Human Ovarian Surface Epithelial Cells1
Tomoharu Okubo,
Samuel C. Mok and
Shiuan Chen
Division of Immunology (T.O., S.C.), Beckman Research Institute of
the City of Hope, Duarte, California 91010; and Laboratory of
Gynecology Oncology, Department of Obstetrics, Gynecology and
Reproductive Biology (S.C.M.), Brigham and Womens Hospital, Harvard
Medical School. Boston, Massachusetts 02115
Address correspondence and requests for reprints to: Dr. Shiuan Chen, Division of Immunology, Beckman Research Institute of the City of Hope, Duarte, California 91010. E-mail: schen{at}coh.org
Ovarian cancer originates mainly from surface epithelial cells,which
are potential targets of estrogen action. Using immunohistochemistry
andRT-PCR analysis, aromatase (estrogen synthetase) can be detectedin
human ovarian surface epithelial tumors. In this study, wefunctionally
characterized the aromatase expressed in a primarycell culture, normal
human ovarian surface epithelial (HOSE)17. The apparent Km
and Vmax values were determined to be 5.8± 0.5
nM, and 0.3 ± 0.0 pmol/mg·h, respectively.The
aromatase activity in HOSE 17 cells can be induced effectivelyby
phorbol esters and forskolin, suggesting that estrogen biosynthesisin
HOSE 17 cells is mainly regulated through protein kinaseC- and protein
kinase A-mediated mechanisms. Exon I-specificRT-PCR revealed that
phorbol esters predominantly up-regulatedpromoter II. Whereas
forskolin treatment increased exon I.3A-containingmessenger RNA, the
aromatase activity remained low in the cellstreated with this agent.
In vitro transcription/translationanalysis using
plasmids containing T7 promoter and the humansnail gene
(SnaH) as a reporter capped with different untranslated
exonIs revealed that exon PII-containing transcripts
were translatedmore effectively than exon I.3-containing transcripts.
Thesefindings explain why aromatase activity is higher in cells with
thePII-containing transcripts than is cells with the I.3-containing
transcripts.Our results indicate that aromatase is functionally
expressedin human ovarian surface epithelial cells and its expression
isregulated at both the transcriptional and translational levels.
This article has been cited by other articles:
H. Wang, R. Li, and Y. Hu The Alternative Noncoding Exons 1 of Aromatase (Cyp19) Gene Modulate Gene Expression in a Posttranscriptional Manner
Endocrinology,
July 1, 2009;
150(7):
3301 - 3307.
[Abstract][Full Text][PDF]
W.-P. Hu, S. K. Tay, and Y. Zhao Endometriosis-Specific Genes Identified by Real-Time Reverse Transcription-Polymerase Chain Reaction Expression Profiling of Endometriosis Versus Autologous Uterine Endometrium
J. Clin. Endocrinol. Metab.,
January 1, 2006;
91(1):
228 - 238.
[Abstract][Full Text][PDF]
Y. Kinoshita and S. Chen Induction of Aromatase (CYP19) Expression in Breast Cancer Cells through a Nongenomic Action of Estrogen Receptor {alpha}
Cancer Res.,
July 1, 2003;
63(13):
3546 - 3555.
[Abstract][Full Text][PDF]